Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
1,780 results
  • Heparin mimetics with anticoagulant activity. [Review]
  • MRMed Res Rev 2018 Feb 15
  • Nahain AA, Ignjatovic V, … Ferro V
  • Heparin, a sulfated polysaccharide belonging to the glycosaminoglycan family, has been widely used as an anticoagulant drug for decades and remains the most commonly used parenteral anticoagulant in ...
  • Anticoagulation for the initial treatment of venous thromboembolism in people with cancer. [Review]
  • CDCochrane Database Syst Rev 2018 01 24; 1:CD006649
  • Hakoum MB, Kahale LA, … Akl EA
  • CONCLUSIONS: LMWH is possibly superior to UFH in the initial treatment of VTE in people with cancer. Additional trials focusing on patient-important outcomes will further inform the questions addressed in this review. The decision for a person with cancer to start LMWH therapy should balance the benefits and harms and consider the person's values and preferences.
  • Anticoagulation in acute coronary syndrome-state of the art. [Review]
  • PCProg Cardiovasc Dis 2018 Jan 13
  • Zeitouni M, Kerneis M, … Montalescot G
  • Early intravenous anticoagulation is the corner stone treatment of patients admitted with an acute coronary syndrome: it antagonizes the ongoing coronary thrombosis and facilitates the percutaneous c...
New Search Next